Adma Biologics (ADMA) Gross Margin (2011 - 2025)
Adma Biologics (ADMA) reported Gross Margin of 63.82% for Q4 2025, up 994.0% on a YoY basis from 5.83% in Q4 2024, and up 13.27% quarter-over-quarter from 56.34% in Q3 2025.
Adma Biologics (ADMA) Gross Margin (2011 - 2025) Analysis & Trends
Adma Biologics has reported Gross Margin for 13 years, with the latest figure at 63.82% in Q4 2025.
- For the quarter ending Q4 2025, Gross Margin rose 994.0% year-over-year to 63.82%; the trailing twelve-month figure through Dec 2025 stood at 57.39% (up 590.0% YoY), and the FY2025 full-year result was 57.39%, up 590.0% from the prior year.
- Gross Margin for Q4 2025 stood at 63.82%, up from 56.34% in the prior quarter.
- The five-year high for Gross Margin was 63.82% in Q4 2025, with the low at 10.73% in Q1 2021.
- Historically, Gross Margin has averaged 31.07% across 5 years, with a median of 28.69% in 2022.
- Annual changes were most pronounced in 2021 — Gross Margin slumped 10582 bps — and 2024, when it jumped 2737 bps.
- Adma Biologics' Gross Margin stood at 6.38% in 2021, then soared by 344 bps to 28.36% in 2022, then surged by 48 bps to 42.06% in 2023, then grew by 28 bps to 53.88% in 2024, then increased by 18 bps to 63.82% in 2025.
- The last three Gross Margin figures came in at 63.82% (Q4 2025), 56.34% (Q3 2025), and 55.11% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 79.04% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 63.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63.82% |
| Sep 30, 2025 | 56.34% |
| Jun 30, 2025 | 55.11% |
| Mar 31, 2025 | 53.22% |
| Dec 31, 2024 | 53.88% |
| Sep 30, 2024 | 49.78% |
| Jun 30, 2024 | 53.60% |
| Mar 31, 2024 | 47.77% |
| Dec 31, 2023 | 42.06% |
| Sep 30, 2023 | 22.41% |
| Jun 30, 2023 | 27.76% |
| Mar 31, 2023 | 29.01% |
| Dec 31, 2022 | 28.36% |
| Sep 30, 2022 | 23.50% |
| Jun 30, 2022 | 10.36% |
| Mar 31, 2022 | 12.58% |
| Dec 31, 2021 | 6.38% |
| Sep 30, 2021 | 1.86% |
| Jun 30, 2021 | -5.62% |
| Mar 31, 2021 | -10.73% |